MERS-CoV Spike Glycoprotein RBD

<strong>MERS-CoV Spike Glycoprotein RBD</strong>_x000D_ <strong>Catalog number:</strong> B2016734_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 27.7 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -80°C_x000D_ <strong>Keywords:</strong> MERS-CoV Spike Glycoprotein Receptor-Binding Domain, Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein RBD, Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein Receptor-Binding Domain_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Choi JA, Goo J, Yang E, Jung DI, Lee S, Rho S, Jeong Y, Park YS, Park H, Moon YH, Park U, Seo SH, Lee H, Lee JM, Cho NH, Song M, Kim JO. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein J Virol. 2020 Nov 23;94(24):e01176-20._x000D_ 2: Goo J, Jeong Y, Park YS, Yang E, Jung DI, Rho S, Park U, Sung H, Park PG, Choi JA, Seo SH, Cho NH, Lee H, Lee JM, Kim JO, Song M. Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein Virus Res. 2020 Mar;278:197863._x000D_ 3: Xiong Q, Cao L, Ma C, Tortorici MA, Liu C, Si J, Liu P, Gu M, Walls AC, Wang C, Shi L, Tong F, Huang M, Li J, Zhao C, Shen C, Chen Y, Zhao H, Lan K, Corti D, Veesler D, Wang X, Yan H. Close relatives of MERS-CoV in bats use ACE2 as their functional receptors Nature. 2022 Dec;612(7941):748-757._x000D_ 4: Zhou Y, Jiang S, Du L. Prospects for a MERS-CoV spike vaccine Expert Rev Vaccines. 2018 Aug;17(8):677-686._x000D_ 5: Ju B, Zhang Q, Ge J, Wang R, Sun J, Ge X, Yu J, Shan S, Zhou B, Song S, Tang X, Yu J, Lan J, Yuan J, Wang H, Zhao J, Zhang S, Wang Y, Shi X, Liu L, Zhao J, Wang X, Zhang Z, Zhang L. Human neutralizing antibodies elicited by SARS-CoV-2 infection Nature. 2020 Aug;584(7819):115-119._x000D_ 6: Tai W, Zheng J, Zhang X, Shi J, Wang G, Guan X, Zhu J, Perlman S, Du L. MERS-CoV RBD-mRNA vaccine induces potent and broadly neutralizing antibodies with protection against MERS-CoV infection Virus Res. 2023 Sep;334:199156._x000D_ 7: Zhang S, Jia W, Zeng J, Li M, Wang Z, Zhou H, Zhang L, Wang X. Cryoelectron microscopy structures of a human neutralizing antibody bound to MERS-CoV spike glycoprotein Front Microbiol. 2022 Sep 28;13:988298._x000D_ 8: Zhou H, Zhang S, Wang X. Crystallization and Structural Determination of the Receptor-Binding Domain of MERS-CoV Spike Glycoprotein Methods Mol Biol. 2020;2099:39-50._x000D_ 9: D'Arco A, Di Fabrizio M, Mancini T, Mosetti R, Macis S, Tranfo G, Della Ventura G, Marcelli A, Petrarca M, Lupi S. Secondary Structures of MERS-CoV, SARS-CoV, and SARS-CoV-2 Spike Proteins Revealed by Infrared Vibrational Spectroscopy Int J Mol Sci. 2023 May 31;24(11):9550._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/38617298">10: Addetia A, Stewart C, Seo AJ, Sprouse KR, Asiri AY, Al-Mozaini M, Memish ZA, Alshukairi A, Veesler D. Mapping immunodominant sites on the MERS-CoV spike glycoprotein targeted by infection-elicited antibodies in humans bioRxiv [Preprint]. 2024 Apr 2:2024.03.31.586409. </a>_x000D_ _x000D_ <strong>Products Related to MERS-CoV Spike Glycoprotein RBD can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>